product summary
company name :
Cell Signaling Technology
product type :
antibody
product name :
INCENP (P240) Antibody
catalog :
2807
clonality :
polyclonal
host :
rabbit
conjugate :
nonconjugated
reactivity :
human
application :
western blot, immunocytochemistry, flow cytometry
citations: 2
Published Application/Species/Sample/DilutionReference
  • immunocytochemistry; human; fig 4
  • western blot; human; fig 3
McKenzie C, Bassi Z, Debski J, Gottardo M, Callaini G, Dadlez M, et al. Cross-regulation between Aurora B and Citron kinase controls midbody architecture in cytokinesis. Open Biol. 2016;6: pubmed publisher
Papini D, Langemeyer L, Abad M, Kerr A, Samejima I, Eyers P, et al. TD-60 links RalA GTPase function to the CPC in mitosis. Nat Commun. 2015;6:7678 pubmed publisher
product information
SKU :
2807S
Product-Name :
INCENP (P240) Antibody
Size :
100 ul
Price-(USD) :
235 USD
Species-x-Reactivity :
H
Applications :
Flow cytometry
Product-Category :
Cell Cycle / Checkpoint Control
Shipping-Temp :
COLD
Storage-Temp :
-20°C
Product-Type :
Polyclonal Antibody
MW :
140
Host :
Rabbit
Target :
INCENP
Primary-Protein :
INCENP
Alt-Names :
FLJ31633,INCE,INCENP,Inner centromere protein,MGC111393,binds and activates aurora-B and -C in vivo and in vitro,chromosomal passenger protein,inner centromere protein INCENP,inner centromere protein antigens 135/155kDa
company information
Cell Signaling Technology
3 Trask Lane
Danvers, MA 01923
info@cellsignal.com
www.cellsignal.com
8776162355
headquarters: USA
Established in Beverly, MA in 1999, Cell Signaling Technology (CST) is a privately-owned company with over 400 employees worldwide. We are dedicated to providing innovative research tools that are used to help define mechanisms underlying cell function and disease. Since its inception, CST has become the world leader in the production of the highest quality activation-state and total protein antibodies utilized to expand knowledge of cell signaling pathways. Our mission is to deliver the world's highest quality research tools that accelerate progress in biological research and personalized medicine.